(Q42703883)

English

Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study

scientific article published on December 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Polymorphisms of CYP2C9, VKORC1, MDR1, APOE and UGT1A1 genes and the therapeutic warfarin dose in Brazilian patients with thrombosis: a prospective cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

Karina Braga Gomes

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

author name string

Vanessa Cristina de Oliveira Almeida

1

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Daniel Dias Ribeiro

2

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Ana Lúcia Brunialti Godard

4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

publication date

1 December 2014

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Molecular Diagnosis and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

18

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

675-683

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

https://scigraph.springernature.com/pub.10.1007/s40291-014-0121-4

0 references

Influence of CYP2C9 and VKORC1 on patient response to warfarin: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Estimation of the warfarin dose with clinical and pharmacogenetic data

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Association of warfarin dose with genes involved in its action and metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

The largest prospective warfarin-treated cohort supports genetic forecasting

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

A polymorphism in the VKORC1 gene is associated with an interindividual variability in the dose-anticoagulant effect of warfarin.

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Influence of genetic, biological and pharmacological factors on warfarin dose in a Southern Brazilian population of European ancestry

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Apolipoprotein E (APOE) and warfarin dosing in an Italian population

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Association of the C3435T polymorphism of the MDR1 gene and therapeutic doses of warfarin in thrombophilic patients

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Analysis of R- and S-hydroxywarfarin glucuronidation catalyzed by human liver microsomes and recombinant UDP-glucuronosyltransferases

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Pharmacodynamic resistance to warfarin is associated with nucleotide substitutions in VKORC1.

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism?

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

The epidemiology of venous thromboembolism.

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Epidemiology and risk factors for venous thrombosis

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Influence of adult age on the total and free clearance and protein binding of (R)- and (S)-warfarin

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Pharmacogenetics of warfarin: development of a dosing algorithm for brazilian patients

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Thirteen novel VKORC1 mutations associated with oral anticoagulant resistance: insights into improved patient diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

CYP2C9 genotypes and the pharmacokinetics of tenoxicam in Brazilians

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Warfarin pharmacogenetics: a single VKORC1 polymorphism is predictive of dose across 3 racial groups

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Pharmacogenomics of anticoagulants: steps toward personal dosage

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

APOE genotype makes a small contribution to warfarin dose requirements.

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Warfarin dose related to apolipoprotein E (APOE) genotype

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

C3435T polymorphism of MDR1 gene with warfarin resistance

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Is there a role for MDR1, EPHX1 and protein Z gene variants in modulation of warfarin dosage? a study on a cohort of the Egyptian population.

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Clinical applicability of sequence variations in genes related to drug metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

CYP2C19 and ABCB1 gene polymorphisms are differently distributed according to ethnicity in the Brazilian general population

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Population diversity and the performance of warfarin dosing algorithms

1 reference

https://api.crossref.org/works/10.1007%2FS40291-014-0121-4

21 January 2018

Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin

1 reference

https://pubmed.ncbi.nlm.nih.gov/25312789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical application of UGT1A1 pharmacogenetic testing: gene-environment interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/25312789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequencies of UDP-glucuronosyltransferase 1 (UGT1A1) gene promoter polymorphisms among distinct ethnic groups from Brazil

1 reference

https://pubmed.ncbi.nlm.nih.gov/25312789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A coding VKORC1 Asp36Tyr polymorphism predisposes to warfarin resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/25312789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Warfarin resistance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25312789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association of apolipoprotein E genotype with duration of time to achieve a stable warfarin dose in African-American patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25312789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apolipoprotein E genotype and warfarin dosing among Caucasians and African Americans

1 reference

https://pubmed.ncbi.nlm.nih.gov/25312789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/25312789

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S40291-014-0121-4

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42703883&oldid=2191242800"